ASST Grande Ospedale Metropolitano Niguarda

5 trials 1 recruiting Academic / non-commercial

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

1 Recruiting

2 Completed trials

7 Countries active

10 Unique IMPs

100% Results reported

Phase III

Phase II/III

Phase II

Phase III: 2 Phase II/III: 1 Phase II: 2

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Colon cancer 1 Richter's syndrome 1 Colon cancer stage IV 1 Colon cancer stage III 1 Colon cancer stage II 1

Top IMPs

ATEZOLIZUMAB 1 COLCHICINE 1 IPILIMUMAB 1 METHYLPREDNISOLONE SODIUM SUCCINATE 1 NIVOLUMAB 1 OBINUTUZUMAB 1 SODIUM CHLORIDE 1 VENETOCLAX 1

All trials

5 total

TOTAL NEOADJUVANT TREATMENT WITHOUT SURGERY FOR LOCALLY ADVANCED RECTAL CANCER: PROSPECTIVE CLINICAL TRIAL TO ASSESS TUMOR COMPLETE RESPONSE… Pending

2024-515225-28-00 Phase II/III 1 country
Single-blinded randomized investigator-initiated controlled trial to assess the efficacy of colchicine to treat patients with cardiomyopathy… Pending

2024-517945-14-00 Phase III 1 country COLCHICINE
Trial to assess the safety and efficacy of high dose pulse intravenous corticosteroid therapy to treat patients with complicated/fulminant a… Recruiting

2023-504169-22-02 Phase III 7 countries METHYLPREDNISOLONE SODIUM SUCCINATE; SODIUM CHLORIDE
A window-of-opportunity trial with high-dose vitamin C to enhance neoadjuvant immune checkpoint therapy in mismatch repair proficient colore… Ended

2022-502524-41-00 Phase II 1 country IPILIMUMAB; NIVOLUMAB
A Clinical Trial Evaluating the Safety and Efficacy of Venetoclax in Combination with Atezolizumab and Obinutuzumab in Richter Transformatio… Ended

2024-516675-32-00 Phase II 1 country ATEZOLIZUMAB; OBINUTUZUMAB; VENETOCLAX

Showing 1–5 of 5 trials

← All sponsors A–Z